Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge
- Conditions
- Pulmonary RehabilitationCOVID-2019 Pneumonia
- Interventions
- Behavioral: Remote pulmonary rehabilitation
- Registration Number
- NCT04368793
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
The noval coronavirus disease 2019 (COVID-19) would cause physical and psychological dysfunctions in infected patients. We expect that an intelligence-based remote pulmonary rehabilitation scheme could improve patients' health status after hospital discharge. The intelligence-based remote pulmonary rehabilitation program is designed in a real-world and prospective manner, aiming to evaluate the efficacy of rehabilitation among 200 patients in the epicenter of China (Wuhan City) according to their varied adherence. An eight-week rehabilitation scheme, including two weeks for physicians and physiotherapists remotely guided training, and six weeks for patient self-management, will be addressed. The primary outcome of current study is six-minute walking distance and lung function, and secondly respiratory muscle strength, physical fitness assessment, symptoms and quality of life, etc. will also be assessed. Recruited patients will be followed up at week 2, 4, 8 after enrollment and at month 1, 3, 6, 12 after the rehabilitation training completed, respectively. The study has been approved by the ethics committee of China-Japan Friendship Hospital and three participating centers in Wuhan City.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Discharged COVID-19 patient cohort Remote pulmonary rehabilitation All enrolled participants will be given 8 weeks (online 2 weeks + offline 6 weeks) pulmonary rehabilitation intervention, and will be followed up for at least one year, to assess their adherence and efficacy of the rehabilitation program.
- Primary Outcome Measures
Name Time Method Six-minute walking distance (6MWD) One year Walking distance within six minutes
Pulmonary function One year Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), etc.
- Secondary Outcome Measures
Name Time Method Respiratory muscle strength One year Maximal inspiratory pressure, maximal expiratory pressure, etc.
Quality of life One year 36-item short-form health survey (SF-36), etc.
Symptom One year Modified British Medical Research Council (mMRC) dyspnea scale, etc.
Physical activity One year International physical activity questionnaire (IPAQ)
Proportion of returning to society One year Proportions of returning to routine work and normal life
Physical fitness assessment One year Two-minute walking test, short physical performance battery, grip strength of both upper limbs, knee extension strength of both lower limbs, etc.
Psychological evaluation One year Self-training depression scale (SDS) and self-rating anxiety scale (SAS)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
Wuhan Lung Hospital
🇨🇳Wuhan, Hubei, China
Wuhan Central Hospital
🇨🇳Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
🇨🇳Wuhan, Hubei, China